Strategic Advisors LLC Sells 1,897 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Strategic Advisors LLC trimmed its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 23.3% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 6,236 shares of the healthcare conglomerate’s stock after selling 1,897 shares during the quarter. Strategic Advisors LLC’s holdings in UnitedHealth Group were worth $3,085,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also recently modified their holdings of the business. Richelieu Gestion SA bought a new stake in UnitedHealth Group in the 4th quarter worth approximately $26,000. CGC Financial Services LLC boosted its stake in shares of UnitedHealth Group by 1,000.0% in the 4th quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after purchasing an additional 50 shares in the last quarter. True Wealth Design LLC bought a new stake in UnitedHealth Group in the fourth quarter worth $31,000. LFA Lugano Financial Advisors SA grew its stake in shares of UnitedHealth Group by 148.1% during the fourth quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock valued at $35,000 after buying an additional 40 shares during the last quarter. Finally, Red Tortoise LLC lifted its stake in shares of UnitedHealth Group by 45.1% in the 1st quarter. Red Tortoise LLC now owns 74 shares of the healthcare conglomerate’s stock valued at $36,000 after acquiring an additional 23 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have weighed in on UNH shares. Cantor Fitzgerald reiterated an “overweight” rating and issued a $591.00 price objective on shares of UnitedHealth Group in a research report on Wednesday, June 12th. Robert W. Baird initiated coverage on shares of UnitedHealth Group in a research report on Thursday, May 30th. They set an “outperform” rating and a $597.00 price target for the company. HSBC raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $580.00 price objective for the company in a research note on Wednesday, June 5th. Truist Financial reiterated a “buy” rating and issued a $600.00 price target on shares of UnitedHealth Group in a report on Wednesday, April 17th. Finally, Barclays boosted their price target on shares of UnitedHealth Group from $534.00 to $560.00 and gave the company an “overweight” rating in a research report on Wednesday, April 17th. Three analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, UnitedHealth Group has an average rating of “Moderate Buy” and an average price target of $579.74.

UnitedHealth Group Stock Performance

NYSE:UNH traded down $4.62 on Friday, hitting $485.27. The stock had a trading volume of 631,253 shares, compared to its average volume of 4,248,694. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $554.70. The stock has a market cap of $446.64 billion, a price-to-earnings ratio of 29.94, a price-to-earnings-growth ratio of 1.44 and a beta of 0.60. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.69. The business’s 50-day simple moving average is $498.61 and its two-hundred day simple moving average is $500.96.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, topping the consensus estimate of $6.63 by $0.28. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The business had revenue of $99.80 billion for the quarter, compared to analysts’ expectations of $99.23 billion. During the same quarter last year, the company posted $6.26 EPS. The company’s revenue was up 8.6% compared to the same quarter last year. As a group, research analysts predict that UnitedHealth Group Incorporated will post 27.55 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 25th. Stockholders of record on Monday, June 17th were given a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a dividend yield of 1.73%. This is an increase from UnitedHealth Group’s previous quarterly dividend of $1.88. The ex-dividend date of this dividend was Monday, June 17th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 51.34%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.